Search clinical trials for: Acamprosate or Naltrexone

Total 5963 results

Hospital Ambroise Paré Paris

Completed

Comparison of the Efficacy of rTMS and tDCS of the Motor Cortex in Patients With Chronic Neuropathic Pain

Lumbar Radiculopathy

France
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
University of Miami

Completed

Optimizing Pharmacotherapy for Bipolar Alcoholics

Alcohol Dependence | Bipolar Disorder

United States
NYU Langone Health
Alkermes, Inc.; New York City Department of Health and Mental Hygiene

Completed

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Opiate Dependence

United States
Indiana University School of Medicine
Brown University; George Washington University; VA Boston Healthcare System

Completed

Research on Individualized Treatment for Alcoholism (RITA)

Alcohol Dependence

United States
Milton S. Hershey Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...

Completed

The Effects of Naltrexone on Active Crohn's Disease (LDN)

Inflammation | Crohn's Disease

United States
Rhode Island Hospital
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Pre-Release VIVITROL for Opioid Dependent Inmates

Substance-Related Disorders

United States
Stanford University
American Fibromyalgia Syndrome Association

Completed

Effects of Low Dose Naltrexone in Fibromyalgia

Fibromyalgia | Persian Gulf Syndrome

United States
Mclean Hospital

Completed

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects (Zyprexa)

Psychotic Disorders | Schizophrenia

United States
Weill Medical College of Cornell University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Naltrexone Treatment for Prolonged Grief Disorder (PGD) (PGD)

Prolonged Grief Disorder

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
GlaxoSmithKline

Completed

To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

Alcoholism

United Kingdom
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Maintenance Treatment of Alcoholism

Alcoholism

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
University of California, San Francisco
The CARESTAR Foundation

Terminated

Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder

Substance Use | Alcohol Use Disorder | Alcohol Abuse or Dependence

United States
Odense University Hospital
University of Southern Denmark; University Hospital Bispebjerg and Frederiksberg

Completed

Fibromyalgia and Naltrexone: The FINAL Study (FINAL)

Fibromyalgia

Denmark
National Institute on Drug Abuse (NIDA)

Completed

Addition of Naltrexone to Methadone Taper

Substance-Related Disorders | Opioid-Related Disorders | Heroin Dependence

United States
Pfizer
Lifetree Clinical Research Center, Salt Lake City, Utah

Completed

A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users

Healthy

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Behavior and Naltrexone Treatment for Alcoholics

Alcoholism

United States
Hospital for Special Surgery, New York

Not yet recruiting

Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome (LDN-CRPS)

Chronic Pain | Complex Regional Pain Syndrome | Causalgia | Complex Regional Pain Syndrome Type I | Complex Regional Pain Syndrome Type II

United States
University of Calgary

Not yet recruiting

Low Dose Naltrexone Use in Patients With POTS

Postural Orthostatic Tachycardia Syndrome
Masonic Cancer Center, University of Minnesota

Terminated

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Breast Cancer

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Behavioral Therapy Plus Naltrexone for Alcoholism

Alcohol Dependence | Alcoholism

United States
Indiana University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Post-Treatment Effects of Naltrexone

Alcoholism

United States
Kangpu Biopharmaceuticals, Ltd.

Completed

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Castration-Resistant Prostate Cancer

United States
University of California, San Francisco
National Institute on Drug Abuse (NIDA)

Completed

Intermittent Naltrexone Among Polysubstance Users (Project iN)

Methamphetamine | Alcohol

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Naltrexone Treatment of Alcohol Dependence

Alcoholism

United States
Yale University
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Opiate Dependence

Russian Federation
Scilex Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety of SP-104

Healthy Volunteers

New Zealand
Brigham and Women's Hospital
Harvard School of Public Health (HSPH); Mclean Hospital

Completed

Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia (IMPACT)

Tuberculosis | Alcohol Use Disorders

Russian Federation
Eunice Kennedy Shriver National Institute of Child...

Unknown

Self-Injury: Diagnosis and Treatment

Self-Injurious Behavior | Mental Retardation

United States
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Completed

Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects

Healthy

United States
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Scilex Pharmaceuticals, Inc.

Completed

Pharmacokinetics of SP-104

Healthy

New Zealand
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade

HIV | Methamphetamine Abuse

United States
Pain Therapeutics

Completed

Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse

Opioid-Related Disorders

United States
Universita di Verona
IGEA

Terminated

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Pancreatic Cancer

Italy
Marta Peciña, MD PhD
Brain & Behavior Research Foundation

Completed

Study of Naltrexone-Induced Blockade of Antidepressant Effects (SONRISA2)

Depression | Major Depressive Disorder

United States
Pfizer

Completed

Pharmacokinetics Study of ALO-02 and OxyContin

Management of Moderate to Severe Pain

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

Alcohol Dependence | Cocaine Dependence

United States
University of Nottingham
University of Wisconsin, Madison

Completed

Factors Associated With Perioperative Outcomes in Non-emergency Surgery

Stroke | Pneumonia | Acute Coronary Syndrome
Pfizer

Completed

Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone

Healthy

United States
Massachusetts General Hospital
United States Department of Defense

Completed

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

ADHD | Stimulant-Induced Euphoria

United States
Allodynic Therapeutics, Inc

Not yet recruiting

Multi-Center Study of Naltrexone-Acetaminophen in Acute Migraine, With an Exploratory Analysis of Co-occurring Anxiety

Migraine
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

Buprenorphine Transdermal Patches Pharmacokinetic Study

Chronic Pain

China
Pfizer

Terminated

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Pfizer

Terminated

Conversion to Embeda With Rescue Trial (ConvERT)

Pain | Chronic Disease

United States
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A First-in-Human Study of QY211 Gel in Adult Subjects

Atopic Dermatitis

China
HK inno.N Corporation

Unknown

A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

Healthy

Korea, Republic of

Search clinical trials for: Acamprosate or Naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations